{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:01Z","timestamp":1790363581108,"version":"4.1.0"},"reference-count":53,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2016,9,24]]},"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Decreasing the diagnostic delay in axial spondyloarthritis (axSpA) remains a major challenge. Here, we assessed the value of serum inflammatory biomarkers to distinguish early axSpA from other pathologies in a large cohort of patients referred with early back pain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum c reactive protein (CRP), erythrocyte sedimentation rate (ESR) and calprotectin were determined in the SPondyloArthritis Caught Early (SPACE) cohort (n=310), an early back pain inception cohort. Additionally, explorative serum biomarkers derived from the literature (interleukin-27 (IL-27), human \u03b2-defensin-2 (hBD-2) and lipcolin-2 (LCN-2)) were determined by ELISA in full-blown patients with ankylosing spondylitis (AS) (n=21) and healthy controls (n=20).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum CRP and ESR levels were not elevated in early axSpA versus \u2018control\u2019 back pain patients. Serum calprotectin was elevated in early axSpA versus controls (p=0.01) but failed to identify early axSpA at the individual level (positive predictive value of 38.7%). As to explorative biomarkers, serum levels of IL-27 were not detectable, and hBD-2 and LCN-2 serum levels were not elevated in full-blown AS versus healthy controls (p=0.572, p=0.562, respectively). Therefore, these markers were not further determined in the SPACE cohort.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>None of the candidate serum inflammatory markers were useful as diagnostic markers in the early phase of axSpA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2016-000319","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T21:22:50Z","timestamp":1484169770000},"page":"e000319","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":44,"title":["Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort"],"prefix":"10.1136","volume":"3","author":[{"given":"Maureen C","family":"Turina","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Yeremenko","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Experimental Immunology, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"van Gaalen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel","family":"van Oosterhout","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Groene Hart Ziekenhuis, Gouda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger J","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Ramonda","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina (M C)","family":"Lebre","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Landew\u00e9","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Baeten","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology and Immunology Center, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Department of Experimental Immunology, Academic Medical Center\/University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"2025090313422812000_3.1.e000319.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24483"},{"key":"2025090313422812000_3.1.e000319.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130588"},{"key":"2025090313422812000_3.1.e000319.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.10.009"},{"key":"2025090313422812000_3.1.e000319.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.511"},{"key":"2025090313422812000_3.1.e000319.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08215-6"},{"key":"2025090313422812000_3.1.e000319.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201766"},{"key":"2025090313422812000_3.1.e000319.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.23471"},{"key":"2025090313422812000_3.1.e000319.8","doi-asserted-by":"publisher","DOI":"10.1186\/ar2794"},{"key":"2025090313422812000_3.1.e000319.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.23901"},{"key":"2025090313422812000_3.1.e000319.10","doi-asserted-by":"crossref","first-page":"e0122693","DOI":"10.1371\/journal.pone.0122693","article-title":"Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-\u03b1 blocking therapy: a prospective longitudinal observational cohort study","volume":"10","author":"Maas","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"2025090313422812000_3.1.e000319.11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/annrheumdis-2015-eular.6285","article-title":"OP0144 The effect of TNF inhibition on radiographic progression in ankylosing spondylitis: an observational cohort study of 384 patients","volume":"74","author":"Maksymowych","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025090313422812000_3.1.e000319.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068734"},{"key":"2025090313422812000_3.1.e000319.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110070"},{"key":"2025090313422812000_3.1.e000319.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131963"},{"key":"2025090313422812000_3.1.e000319.15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110767"},{"key":"2025090313422812000_3.1.e000319.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.20990"},{"key":"2025090313422812000_3.1.e000319.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-002-0237-4"},{"key":"2025090313422812000_3.1.e000319.18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205590"},{"key":"2025090313422812000_3.1.e000319.19","first-page":"561","article-title":"Ankylosing spondylitis: how diagnostic and therapeutic delay have changed over the last six decades","volume":"30","author":"Salvadorini","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313422812000_3.1.e000319.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep393"},{"key":"2025090313422812000_3.1.e000319.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.071605"},{"key":"2025090313422812000_3.1.e000319.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.24838"},{"key":"2025090313422812000_3.1.e000319.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.120139"},{"key":"2025090313422812000_3.1.e000319.24","doi-asserted-by":"publisher","DOI":"10.1002\/art.10988"},{"key":"2025090313422812000_3.1.e000319.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.21914"},{"key":"2025090313422812000_3.1.e000319.26","doi-asserted-by":"publisher","DOI":"10.1002\/path.1758"},{"key":"2025090313422812000_3.1.e000319.27","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-014-0413-4"},{"key":"2025090313422812000_3.1.e000319.28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205506"},{"key":"2025090313422812000_3.1.e000319.29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10238-014-0281-x","article-title":"Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity","volume":"15","author":"Lin","year":"2014","journal-title":"Clin Exp Med"},{"key":"2025090313422812000_3.1.e000319.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1227-3"},{"key":"2025090313422812000_3.1.e000319.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004725"},{"key":"2025090313422812000_3.1.e000319.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04265.x"},{"key":"2025090313422812000_3.1.e000319.33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","article-title":"Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI","volume":"305","author":"Roman\u00ed","year":"2013","journal-title":"Arch Dermatol Res"},{"key":"2025090313422812000_3.1.e000319.34","first-page":"519","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity","volume":"47","author":"Oikonomou","year":"2012","journal-title":"J Gastroenterol Japan"},{"key":"2025090313422812000_3.1.e000319.35","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2676-z"},{"key":"2025090313422812000_3.1.e000319.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.07.016"},{"key":"2025090313422812000_3.1.e000319.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61134-4"},{"key":"2025090313422812000_3.1.e000319.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207544"},{"key":"2025090313422812000_3.1.e000319.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60071-8"},{"key":"2025090313422812000_3.1.e000319.40","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket164"},{"key":"2025090313422812000_3.1.e000319.41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201270"},{"key":"2025090313422812000_3.1.e000319.42","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018"},{"key":"2025090313422812000_3.1.e000319.43","doi-asserted-by":"publisher","DOI":"10.1002\/art.21426"},{"key":"2025090313422812000_3.1.e000319.44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.10.927"},{"key":"2025090313422812000_3.1.e000319.45","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1528-x"},{"key":"2025090313422812000_3.1.e000319.46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02201003","article-title":"Caeruloplasmin, prealbumin and u2-macroglobulin as potential indices of disease activity in different arthritides","volume":"6","author":"Surrall","year":"1987","journal-title":"Clin Rheumatol"},{"key":"2025090313422812000_3.1.e000319.47","doi-asserted-by":"publisher","DOI":"10.1002\/art.20696"},{"key":"2025090313422812000_3.1.e000319.48","doi-asserted-by":"publisher","DOI":"10.1002\/art.22589"},{"key":"2025090313422812000_3.1.e000319.49","doi-asserted-by":"publisher","DOI":"10.1002\/art.20477"},{"key":"2025090313422812000_3.1.e000319.50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei208"},{"key":"2025090313422812000_3.1.e000319.51","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-010-1018-0"},{"key":"2025090313422812000_3.1.e000319.52","doi-asserted-by":"publisher","DOI":"10.1002\/art.33396"},{"key":"2025090313422812000_3.1.e000319.53","doi-asserted-by":"publisher","DOI":"10.1002\/art.37704"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2016-000319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:42:36Z","timestamp":1756932156000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2016-000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,11]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1136\/rmdopen-2016-000319"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2016-000319","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}